Applied Pharmaceutical Chemistry 2025!
In-Person at Pfizer
1 Portland Street
Cambridge, MA 02139
Thursday, April 10, 2025
Confirmed speakers for APC 2024
Keynote Lecture: Lyn Jones, PhD Director of the Center for Protein Degradation at Dana-Farber Cancer Institute Next-Generation Covalent Drug Discovery – Targeting Residues Beyond Cysteine |
Keynote Lecture: John A Porco, Jr., PhD CMD Director and Professor of Chemistry @ Boston University Chemical Synthesis of Complex Molecules for Translational Science |
||
Kevin Cottrell, PhD Executive Director, Medicinal Chemistry @ Tango Therapeutics MTA-cooperative PRMT5 Inhibitors For the Treatment of MTAP-deleted Cancers |
Bernhard Fasching, PhD Vice President, Chemistry @ Monte Rosa Therapeutics Rational Discovery and Design of Molecular Glue Degraders |
||
David Griffith, PhD Research Fellow @ Pfizer Small Molecule GLP-1 Receptor Agonists Suitable for Once-daily Oral Administration
|
Eileen Hoang, PhD Scientist, Process Chemistry @ Sanofi Sustainability-Driven Science: How Process Chemistry at Sanofi Integrates Eco-Design with Process Development |
||
Hong Myung Lee, PhD Principal Scientist @ Takeda Pharmaceuticals Identification of A Novel Linker Enabling Bioconjugation of A Cyclic Dinucleotide For the STING Antibody Drug Conjugate TAK-500 |
Mike Visser, PhD Director @ Novartis Institutes for Biomedical Research Discovery and Characterization of a First-In-Class Selective IKZF2 Glue Degrader for Immuno-Oncology Applications |
||
Matthew Weiss, PhD Executive Director, Head of Medicinal Chemistry @ Kymera Therapeutics Discovery of Potent, Orally Bioavailable IRAK4 Degraders for the Treatment of Oncology and Immuno-Inflammatory Diseases |
Abba Leffler Senior Principal Scientist @ Schrodinger Exploiting High-Energy Hydration Sites for the Discovery of Potent Peptide Aldehyde Inhibitors of the SARS-CoV-2 Main Protease with Cellular Antiviral Activity |
Download APC 2023 Conference Program
Join our LinkedIn Group